Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins

Atorvastatin affects TLR4 clustering via lipid raft modulation

(2010) Praveen Chansrichavala et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Celecoxib Combined with Atorvastatin Prevents Progression of Atherosclerosis

(2010) Mihir Raval et al.   JOURNAL OF SURGICAL RESEARCH

Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-κB expression

(2010) Lina Wang et al.   NEUROSCIENCE LETTERS

Inflammatory and Neuroimmunomodulatory Changes in Acute Cerebral Ischemia

(2009) David Brea et al.   CEREBROVASCULAR DISEASES

The Association between Inflammatory Markers and Carotid Atherosclerosis Is Sex Dependent: the Tromsø Study

(2009) Dag S. Halvorsen et al.   CEREBROVASCULAR DISEASES

Effects of Atorvastatin on Carotid Atherosclerotic Plaques: A Randomized Trial for Quantitative Tissue Characterization of Carotid Atherosclerotic Plaques with Integrated Backscatter Ultrasound

(2009) Kiyofumi Yamada et al.   CEREBROVASCULAR DISEASES

ESVS Guidelines. Invasive Treatment for Carotid Stenosis: Indications, Techniques

(2009) C.D. Liapis et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques

(2009) Athanasios Katsargyris et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Immunomodulatory and Anti-Inflammatory Activities of Statins

(2009) Emilia Mira et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?

(2008) Athanasios Katsargyris et al.   EXPERT OPINION ON THERAPEUTIC TARGETS